Sale!

GLUL Gene Glutamine Deficiency Congenital Genetic Test

Original price was: $700.Current price is: $500.

-29%

The GLUL Gene Glutamine Deficiency Congenital NGS Genetic DNA Test is a specialized diagnostic examination that identifies mutations in the GLUL gene responsible for congenital glutamine deficiency. This rare metabolic disorder affects the body’s ability to produce glutamine, an essential amino acid crucial for brain function, immune system support, and nitrogen transport. Using Next-Generation Sequencing (NGS) technology, this test provides comprehensive analysis of the GLUL gene to detect pathogenic variants that may cause this serious condition. Early detection through this $500 USD test enables timely intervention and management strategies. The test is particularly important for infants and children showing developmental delays, neurological symptoms, or metabolic abnormalities. Results are typically available within 3-4 weeks, providing families with critical information for medical decision-making and treatment planning.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

GLUL Gene Glutamine Deficiency Congenital NGS Genetic DNA Test

Understanding Congenital Glutamine Deficiency

Congenital glutamine deficiency is a rare autosomal recessive metabolic disorder caused by mutations in the GLUL gene, which encodes the enzyme glutamine synthetase. This essential enzyme plays a critical role in converting glutamate and ammonia into glutamine, one of the most abundant amino acids in the human body. Glutamine serves multiple vital functions, including neurotransmitter synthesis, immune system regulation, and maintaining acid-base balance. When the GLUL gene contains pathogenic variants, the body cannot produce sufficient glutamine, leading to severe neurological complications and metabolic disturbances that typically manifest in early infancy.

What This Advanced Genetic Test Detects

The GLUL Gene Glutamine Deficiency Congenital NGS Genetic DNA Test utilizes cutting-edge Next-Generation Sequencing technology to comprehensively analyze the entire GLUL gene for pathogenic mutations. This sophisticated testing approach examines:

  • Point mutations and single nucleotide variants
  • Small insertions and deletions (indels)
  • Copy number variations affecting the GLUL gene
  • Regulatory region abnormalities
  • Splice site mutations that may affect gene expression

The test provides a complete genetic profile of the GLUL gene, enabling accurate diagnosis of congenital glutamine deficiency and helping to distinguish it from other metabolic disorders with similar clinical presentations.

Who Should Consider This Genetic Screening?

Clinical Indications and Symptoms

This test is recommended for individuals presenting with symptoms suggestive of congenital glutamine deficiency, including:

  • Newborns with unexplained seizures or encephalopathy
  • Infants displaying developmental delays and failure to thrive
  • Children with neurological abnormalities and cognitive impairment
  • Patients with family history of metabolic disorders or consanguineous parents
  • Individuals with unexplained hyperammonemia or metabolic acidosis
  • Patients with abnormal brain MRI findings suggestive of metabolic disease

Comprehensive Benefits of Early Detection

Early diagnosis through the GLUL Gene Glutamine Deficiency Test offers numerous advantages:

  • Timely Intervention: Enables prompt initiation of glutamine supplementation therapy
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Treatment Guidance: Helps develop personalized management strategies
  • Prognostic Information: Offers insights into disease progression and potential outcomes
  • Differential Diagnosis: Distinguishes glutamine deficiency from other metabolic disorders

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our expert genetic counselors and metabolic specialists. Possible outcomes include:

  • Positive Result: Identification of pathogenic mutations in the GLUL gene confirms congenital glutamine deficiency diagnosis
  • Negative Result: No disease-causing variants detected, though clinical correlation remains essential
  • Variant of Uncertain Significance: Identification of genetic changes with unclear clinical implications requiring further evaluation
  • Carrier Status: Detection of single mutated copy in asymptomatic individuals

All positive results include detailed recommendations for management, treatment options, and family member testing considerations.

Test Information and Pricing

Test Component Details
Test Name GLUL Gene Glutamine Deficiency Congenital NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Nationwide Accessibility and Support

We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our facilities are equipped with state-of-the-art genetic testing technology and staffed by experienced genetic counselors and metabolic specialists.

Take the First Step Toward Diagnosis

If you or your loved one is experiencing symptoms suggestive of congenital glutamine deficiency, don’t delay in seeking proper diagnosis. Early detection can significantly impact treatment outcomes and quality of life. Our team of genetic specialists is ready to provide comprehensive testing, counseling, and support throughout your diagnostic journey.

Book your GLUL Gene Glutamine Deficiency Congenital NGS Genetic DNA Test today by calling our genetic counseling hotline at +1(267) 388-9828 or schedule your appointment online. Take control of your genetic health with America’s leading metabolic genetics testing provider.